---
title: "Jincheng Pharm: Mirabegron has obtained approval for the listing application of chemical raw materials"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/258476902.md"
description: "According to the Zhitong Finance APP, Jincheng Pharm announced that its wholly-owned subsidiary Beijing Jincheng Tail Pharmaceutical Co., Ltd. recently received the \"Approval Notice for the Listing Application of Chemical Raw Materials\" issued by the National Medical Products Administration. The name of the chemical raw material is: Mirabegron. Mirabegron is a selective β-3 adrenergic receptor agonist, primarily used for the treatment of overactive bladder (OAB), including symptoms such as urinary incontinence, urgency, and frequency"
datetime: "2025-09-23T08:19:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/258476902.md)
  - [en](https://longbridge.com/en/news/258476902.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/258476902.md)
---

# Jincheng Pharm: Mirabegron has obtained approval for the listing application of chemical raw materials

According to the Zhitong Finance APP, Jincheng Pharm (300233.SZ) announced that its wholly-owned subsidiary, Beijing Jincheng Tail Pharmaceutical Co., Ltd., recently received the "Approval Notice for the Listing Application of Chemical Raw Materials" issued by the National Medical Products Administration. The name of the chemical raw material is: Mirabegron. Mirabegron is a selective β-3 adrenergic receptor agonist, primarily used for the treatment of overactive bladder (OAB), including symptoms such as urinary incontinence, urgency, and frequency

### Related Stocks

- [300233.CN](https://longbridge.com/en/quote/300233.CN.md)

## Related News & Research

- [TI: Record revenue and EBITDA growth, first graphite deals, and strong zinc output drive robust results](https://longbridge.com/en/news/295690097.md)
- [CTT Pharmaceutical explores contract manufacturing partnership, talks ongoing](https://longbridge.com/en/news/295684783.md)
- [Volta Metals agrees to buy three Ontario mining claims near Springer rare earth deposit for 600,000 shares](https://longbridge.com/en/news/295516928.md)
- [NeuroThera wins Japanese patent for 4-aminophenol, N-acylethanolamine therapy combo](https://longbridge.com/en/news/295662231.md)
- [CaixaBank says prepaid card purchase volume tops 1 billion in first half, up over 10%](https://longbridge.com/en/news/295381999.md)